Aflatoxin B1 modulates the insulin-like growth factor-2 dependent signaling axis

Toxicology in Vitro

Volumn 24, Issue 3, 2010, Pages 783-789

  Ubagai, Tsuneyuki ^a   Kikuchi, Takane ^a   Fukusato, Toshio ^a   Ono, Yasuo ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fetoprotein; Aflatoxin B1; Hepatocellular carcinoma; Insulin like growth factor 1 receptor; Insulin like growth factor 2; qPCR

Indexed keywords

AFLATOXIN B1; ALPHA FETOPROTEIN; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR; CARCINOGEN; DNA; PRIMER DNA; RNA;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; RNA TRANSLATION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; GENETICS; LIVER TUMOR; METASTASIS; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

AFLATOXIN B1; ANIMALS; BLOTTING, WESTERN; CARCINOGENS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LIVER NEOPLASMS, EXPERIMENTAL; NEOPLASM METASTASIS; PHOSPHORYLATION; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SIGNAL TRANSDUCTION;

EID: 77649183122     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.12.022     Document Type: Article

References (22)

1. 1-induce carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and in rat. Cancer Research 65 (2005) 1265-1270
2. Bennett J.W., and Klich M. Mycotoxins. Clinical Microbiological Review 16 (2003) 497-516
3. Breuhahn K., Longerich T., and Schirmacher P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 25 (2006) 3787-3800
4. Busby W.F., and Wogan G.N. Aflatoxins. In: Searle C.E. (Ed). Chemical Carcinogens vol. 2 (1984), American Chemical Society, Washington, DC 945-1136
5. Doi I. Establishment of a cell line and its clonal sublines from patient with hepatoblastoma. Gann 67 1 (1976) 1-10
6. In: Eaton D.L., and Groopman J.D. (Eds). The toxicology of aflatoxins: human health, veterinary, and agricultural significance (1994), Academic Press, San Diego, CA, USA
7. Herceg Z. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 22 (2007) 91-103
8. International Agency for Research on Cancer, 1982. The evaluation of the carcinogenic risk of chemicals to humans. IARC Monograph Supplement 4. International Agency for Research on Cancer, Lyon, France.
9. Lee Y.I., Lee S., Das G.C., Park U.S., Park S.M., and Lee Y.I. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma. Oncogene 19 (2000) 3717-3726
10. Lee Y.I., Han Y.J., Lee S.Y., Lee Y.I., Park S.K., Park Y.J., Moon H.B., Shin J.H., and Lee J.H. Activation of insulin-like growth factor II signaling by mutation type p53: physiological implication of IGF-II signaling by p53 mutant 249. Molecular and Cellular Endocrinology 203 (2003) 51-63
11. Luis P., Gonzale-Garcia M., Page C., Herrera R., and Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278 (1997) 687-689
12. Macnab G.M., Alexander J.J., Lecatsas G., Bey E.M., and Urbanowicz J.M. Hepatitis B surface antigen produced by a human hepatoma cell line. British Journal of Cancer 34 (1976) 509-515
13. Ming L., Thorgeirsson S.S., Gail M.H., Lu P., Harris C.C., Wang H., Shao Y., Wu Z., Liv G., Wang X., and Sun Z. Dominant role of hepatitis B virus and cofactor of aflatoxin in hepatocarcinogenesis in Quidong, China. Hepatology 36 (2002) 1214-1220
14. Riedemann J., and Macaulay V.M. IGF1R signaling and its inhibition. Endocrine-Related Cancer 13 (2006) S33-S44
15. Schirmacher P., Held W.A., Yang D., Chisari F.V., Rustum Y., and Rogler C.E. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Research 52 (1992) 2549-2556
16. Sell S. Mouse models to study the interaction of risk factors for human liver cancer. Cancer Research 63 (2003) 7553-7562
17. Ubagai T., Tansho S., Ito T., and Ono Y. Influences of aflatoxin B1 on reactive oxygen species generation and chemotaxis of human polymorphonuclear leukocytes. Toxicology in Vitro 22 (2008) 1115-1120
18. Wang J.S., Huang T., Su J., Liang F., Wei Z., Liang Y., Luo H., Kuang S.Y., Qian G.S., Sun G., He X., Kensler T.W., and Groopman J.D. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China. Cancer Epidemiology, Biomarkers and Prevention 10 (2001) 143-146
19. Williams J.H., Phillips T.D., Jolly P.E., Stiles J.K., Jolly C.M., and Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. American Journal of Clinical Nutrition 80 (2004) 1106-1122
20. Xu X.R., Huang J., Xu Z.G., Qian B.Z., Zhu Z.D., Yan Q., Cai T., Zhang X., Xiao H.S., Qu J., Liu F., Huang Q.H., Cheng Z.H., Li N.G., Du J.J., Hu W., Shen K.T., Lu G., Fu G., Zhong M., Xu S.H., Gu W.Y., Huang W., Zhao X.T., Hu G.X., Gu J.R., Chen Z., and Han Z.G. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 15089-15094
21. Yang D., Faris R., Hixson D., Affigne S., and Rogler C.E. Insulin-like growth factor II blocks apoptosis of N-myc2-expressing woodchuck liver epithelial cells. Journal of Virology 70 (1996) 6260-6268
22. Yang C.F., Liu J., Wasser S., Shen H.M., Tan E.L., and Ong C.N. Inhibition of ebselen on aflatoxin B1-induced hepatocarcinogenesis in Fischer 344 rats. Carcinogenesis 21 (2000) 2237-2243